6533b7ddfe1ef96bd12735b0
RESEARCH PRODUCT
Effects of aspirin, nimesulide, and SC-560 on vasopressin-induced contraction of human gastroepiploic artery and saphenous vein.
Gloria SegarraEva SernaMaría Dolores MauricioBelen CortinaMartin AldasoroJosé M. VilaSalvador LluchPascual MedinaBlas Florsubject
MaleVasopressinVasopressinsNeuropeptideGastroepiploic ArteryPharmacologyCritical Care and Intensive Care MedicineMuscle Smooth VascularCoronary artery bypass surgeryIntensive careMedicineHumansCyclooxygenase InhibitorsSaphenous VeinAgedAged 80 and overAspirinSulfonamidesbiologyAspirinDose-Response Relationship Drugbusiness.industryMiddle AgedAnesthesiabiology.proteinPyrazolesFemaleCyclooxygenasebusinessGastroepiploic ArteryNimesulidemedicine.drugMuscle Contractiondescription
Objective: The present experiments were designed to evaluate differences in the effects of cyclooxygenase (COX)-1 and COX-2 inhibition on contractile responses of human gastroepiploic artery and saphenous vein elicited by vasopressin. Design: Laboratory investigation. Setting: University laboratory. Subjects: Rings of human gastroepiploic artery were obtained from 32 patients undergoing gastrectomy, and rings of saphenous vein were obtained from 30 patients undergoing coronary artery bypass surgery. Interventions: The rings were suspended in organ baths for isometric recording of tension. We studied the responses to vasopressin in the absence and in the presence of either the vasopressin V 1 -receptor antagonist d(CH 2 ) 5 Tyr(Me)AVP or the COX inhibitors aspirin, nimesulide, or SC-560. Measurements and Main Results: Vasopressin (10 -11 -10 -6 mol/L) produced concentration-dependent contractions with an EC 50 value of 4.3 x 10 -10 mol/L for gastroepiploic artery and 3.4 x 10 -8 mol/L for saphenous vein. The vasopressin V 1 -receptor antagonist d(CH 2 ) 5 Tyr(Me)AVP (10 -7 mol/L) induced significant shifts (p <.001) of the control curves to the right. The COX-1 and COX-2 inhibitor aspirin (10 -6 -10 -5 mol/L) and the COX-2 inhibitor nimesulide (10 -6 mol/L) induced leftward shifts of the concentration-response curve for vasopressin in gastroepiploic artery. Lower concentrations of aspirin or the COX-1 inhibitor SC-560 (10 -8 mol/L) did not affect the responses of gastroepiploic artery. COX-1 or COX-2 inhibition did not modify the contraction of saphenous vein to vasopressin. Conclusion: The results provide functional evidence that aspirin at high concentrations and the COX-2 selective inhibitor nimesulide potentiate the contractile response of gastroepiploic artery to vasopressin, thus suggesting the release of relaxant prostaglandins by the peptide. However, contractions of human saphenous vein were unaffected by COX inhibition, indicating that vasopressin does not stimulate the release of prostanoids. The amplifying effect of aspirin on vasopressin-induced contraction may contribute to early graft failure when the gastroepiploic artery is used as a coronary artery bypass graft.
year | journal | country | edition | language |
---|---|---|---|---|
2007-12-20 | Critical care medicine |